🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2818567 83 F IL 12/30/2024 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Condition aggravated, Herpes virus infection; Condition aggravated, Herpes virus... Condition aggravated, Herpes virus infection; Condition aggravated, Herpes virus infection, Herpes zoster, Pruritus More
pt says a few days after getting the vaccine broke out with a severe case of herpes out break- flare... pt says a few days after getting the vaccine broke out with a severe case of herpes out break- flare up. This was around her waist line and a few around her buttocks. She has been applying cool towels and using hydrocortisone cream. She normally take Acyclovir when she has a flare up but she has taken 2 doses and this has not helped at all. She believes that because on this medication she should not have taken this vaccine and the pharmacy should have asked her before giving it to her. She will contact her PCP to find out how to treat. More
2780734 71 F CA 07/23/2024 VARZOS
VARZOS
VARZOS
VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

yz9f7
yz9f7
YZ9F7
Arthritis, Computerised tomogram abnormal, Magnetic resonance imaging abnormal, ... Arthritis, Computerised tomogram abnormal, Magnetic resonance imaging abnormal, X-ray limb abnormal; Mobility decreased, Musculoskeletal stiffness, Pain; Arthritis, Computerised tomogram abnormal, Magnetic resonance imaging abnormal, X-ray limb abnormal; Mobility decreased, Musculoskeletal stiffness, Pain; Arthralgia, Neck pain More
I had no idea what I had. I heard from other people about Frozen Shoulder. I went to this orthopedic... I had no idea what I had. I heard from other people about Frozen Shoulder. I went to this orthopedic that I see for my foot (Dr.). He did an xray and MRI. He said I have terrible arthritis in that shoulder (left shoulder). I didnt do anything to hurt it. I went to him in October of 2023. I couldnt take it anymore, the pain was so bad. He did write me a prescription, he gave me an injection of a steroid, and it did not do anything. I went to rehab at Physical Therapy, was seen end of 2023 and beginning of year 2024. I also saw Dr. -April or May 2024 More
2823854 1.25 M FL 01/30/2025 DTAP
HIBV
PNC20
 SANOFI PASTEUR
SANOFI PASTEUR
PFIZER\WYETH
 3CA25C1
UK169AC
LG5578
Injection site erythema, Injection site swelling; Injection site erythema, Injec... Injection site erythema, Injection site swelling; Injection site erythema, Injection site swelling; Injection site erythema, Injection site swelling More
Left thigh redness & swelling from injection site down to above knee. Left thigh redness & swelling from injection site down to above knee.
2823387 U 01/29/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Autism spectrum disorder Autism spectrum disorder
gave them autism; This serious case was reported by a consumer and described the occurrence of autis... gave them autism; This serious case was reported by a consumer and described the occurrence of autism in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included infliximab for product used for unknown indication. On an unknown date, the patient received Shingrix and infliximab. On an unknown date, an unknown time after receiving Shingrix, the patient experienced autism (Verbatim: gave them autism) (serious criteria GSK medically significant). The action taken with infliximab was unknown. The outcome of the autism was resolved. It was unknown if the reporter considered the autism to be related to Shingrix. The company considered the autism to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 17-JAN-2025 The reporter reported that the patient got Shingrix when they started infliximab and it gave them autism. On an unknown date, an unknown time after receiving infliximab, the patient experienced autism. It was unknown if the reporter considered the autism to be related to infliximab. This case has been linked to the US2025AMR010349 case reported by the same reporter.; Sender's Comments: Autism spectrum disorder is an unlisted event which is considered unrelated to GSK vaccine Shingrix. US-GSK-US2025AMR010349:same reporter More
2823388 U 01/29/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Product preparation issue Product preparation issue
Maladministration of the AS01B Adjuvant of Shingrix Alone; Maladministration of the AS01B Adjuvant o... Maladministration of the AS01B Adjuvant of Shingrix Alone; Maladministration of the AS01B Adjuvant of Shingrix Alone; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 30-DEC-2024, the patient received the 2nd dose of Shingrix. On 30-DEC-2024, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Maladministration of the AS01B Adjuvant of Shingrix Alone) and inappropriate dose of vaccine administered (Verbatim: Maladministration of the AS01B Adjuvant of Shingrix Alone). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 30-DEC-2024 The reporter reported that a patient received Shingrix diluent alone without the powder portion, which led to an inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter believed this was patient's Shingrix second dose. There was no patient's information available, nor lot number or expiration date information either. The vaccine administration facility was the same as primary reporter. More
2823389 56 F NY 01/29/2025 FLU3
 SANOFI PASTEUR
 UT8408LA
Drug ineffective, Influenza, Influenza A virus test positive, Myalgia, Pyrexia Drug ineffective, Influenza, Influenza A virus test positive, Myalgia, Pyrexia
came down with flu type a. got a positive result on the rapid flu a test/got sick with flu; fever; s... came down with flu type a. got a positive result on the rapid flu a test/got sick with flu; fever; severe muscle aches; lack of efficacy. got sick with flu a; Initial information received on 23-Jan-2025 regarding an unsolicited valid non-serious case received from patient This case involves a 56 years old female patient who got a positive result on the rapid flu a test/got sick with flu, fever, severe muscle aches and indicating lack of efficacy after receiving influenza USP trival A-B subvirion NO preservative vaccine [Fluzone]. The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided. On 06-Dec-2024, the patient received 0.5 ml of suspect influenza USP trival A-B subvirion NO preservative vaccine Suspension for injection (Unknown strength) with lot UT8408LA and expiry date JUN-2026 via intramuscular route in unknown administration site for Flu prevention (Antiviral prophylaxis) On 19-Jan-2025 the patient developed came down with flu type a. got a positive result on the rapid flu a test/got sick with flu (influenza a virus test positive), fever (pyrexia), muscle aches (myalgia) and lack of efficacy. got sick with flu a (vaccination failure) (Latency 1 month 13 days) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE. Relevant laboratory test results included: Influenza A virus test - On 19-Jan-2025: Positive Action taken was not applicable. It was not reported if the patient received a corrective treatment for all the events. At time of reporting, the outcome was Recovering / Resolving for all the events. More
2823390 0.42 M NC 01/29/2025 DTAPIPVHIB
 SANOFI PASTEUR
 UK167AA
No adverse event, Product preparation issue No adverse event, Product preparation issue
Only the DTaP-IPV component was administered to the patient/The Hib component was not yet administer... Only the DTaP-IPV component was administered to the patient/The Hib component was not yet administered, with no reported adverse event; Initial information received on 21-Jan-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 5 months old male patient to whom only the dtap-ipv component of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)] was administered to the patient/the hib component was not yet administered, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20) for Immunisation. On 21-Jan-2025, only the dtap-ipv component was administered to the patient at unknown dose of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, Powder and suspension for suspension for injection (lot UK167AA; Expiration date: 20-Oct-2025 strength not reported) via intramuscular route in unknown administration site for Immunization, hib component was not yet administered, with no reported adverse event (single component of a two-component product administered) (latency: on same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2823391 0.33 M SC 01/29/2025 DTAPIPVHIB
 SANOFI PASTEUR
 49281-561-01
No adverse event, Wrong technique in product usage process No adverse event, Wrong technique in product usage process
pentacel components being administered separately with no reported adverse event; Initial informatio... pentacel components being administered separately with no reported adverse event; Initial information received on 22-Jan-2025 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to US-SA-2025SA023518 (Cluster case). This case involves a 4 months old male patient who had Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] components being administered separately with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE for Immunisation. On 21-Jan-2025, the patient received a 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine (lot 49281-561-01 and 49281-51105, with strength as Standard and unknown expiry) via intramuscular route in the left thigh as Immunization, but on this date only the DTaP-IPV liquid vaccine component was administered and next day on 22-Jan-2025 received an unknown dose of ActHIB vaccine component via intramuscular route in the right thigh leading to pentacel components being administered separately with no reported adverse event (wrong technique in product usage process) (Latency: same day). Reportedly, Caregiver is unsure if the ActHIB that was administered today was the lyophilized vaccine component of PENTACEL from yesterday or if it was the actual vaccine. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA023518:02383817 More
2823392 1 F TX 01/29/2025 MEN
 UNKNOWN MANUFACTURER
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Menquadfi since it was administered to a patient below 2 years old with no reported adverse event; I... Menquadfi since it was administered to a patient below 2 years old with no reported adverse event; Initial information received on 22-Jan-2025 regarding an unsolicited valid non-serious case received from a Patient. This case involves a 1 years old female patient (below 2 years old) was administered Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Jan-2025, a below2 years old patient was administered (dose 1) (Standard) Meningococcal A-C-Y-W135 (T Conj) Vaccine (frequency-once) (unknown strength, expiry date, batch number and route) in the left thigh for immunization with no reported adverse event (product administered to patient of inappropriate age) (latency-same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Reportedly, Caregiver called to inquire of possible side effects with Menquadfi and how long to look out for possible side effects. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2823393 0.33 M SC 01/29/2025 HIBV
 SANOFI PASTEUR
No adverse event, Product preparation issue No adverse event, Product preparation issue
ACTHIB administered separately from Pentacel with no reported adverse event; Initial information rec... ACTHIB administered separately from Pentacel with no reported adverse event; Initial information received on 22-Jan-2025 regarding an unsolicited valid non-serious case received from a nurse. The case is linked to US-SA-2025SA023490. This case involves a 4 months old male patient who had HIB (PRP/T) Vaccine [ACT-HIB] administered separately from pentacel with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE and DTAP WITH POLIO for Immunisation. On 22-Jan-2025, the patient received a dose of 0.5 ml of suspect HIB (PRP/T) Vaccine (Powder and solvent for solution for injection) strength, expiry date, lot number not reported via intramuscular route in the right thigh for Immunization and acthib administered separately from pentacel with no reported adverse event (wrong technique in product usage process) (latency : same day). The information on batch number and expiration date corresponding to the one at time of event occurrence was requested. Reportedly "ActHIB that was administered today was the lyophilized vaccine component of PENTACEL from yesterday or if it was the actual vaccine. Nurse caregiver wanted to know if there are possible side effects since it was given incorrectly." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA023490:02383817 More
2823394 0.5 M NY 01/29/2025 DTAPIPVHIB
 SANOFI PASTEUR
Extra dose administered, No adverse event, Product preparation issue Extra dose administered, No adverse event, Product preparation issue
patient who was due to get a shot of PENTACEL but the provider only administered the diluent part of... patient who was due to get a shot of PENTACEL but the provider only administered the diluent part of the product with no reported adverse event; Patient was administered with 2 doses of the diluents back to back with about a 5 minute interval; Initial information received on 23-Jan-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves a 6 months old male patient who was administered with the diluent part of the diphtheria/tetanus/5 HYBRID AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] and patient was administered with 2 doses of the diluents back to back with about a 5 minute interval with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Jan-2025, the patient received the diluent part of the diphtheria/tetanus/5 HYBRID AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection with standard strength (expiry date, lot number and dose not reported) via unknown route in unknown administration site as Immunization (single component of a two-component product administered) and was administered with 2 doses of the diluents back to back with about a 5 minute interval (extra dose administered) (same day latency). Reportedly, caller asked on the dosing for the patient's next dose, since the patient was supposed to get it at 18 months, they wanted to know if the patient should only be given with Hib since the patient already got 2 doses of the DTAP-IPV. Information on the batch number was requested corresponding to the one at time of event occurrence. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2823395 18 F NY 01/29/2025 TDAP
 SANOFI PASTEUR
Exposure during pregnancy, Extra dose administered Exposure during pregnancy, Extra dose administered
pregnant patient received a second dose of ADACEL in error with no reported adverse event; Initial i... pregnant patient received a second dose of ADACEL in error with no reported adverse event; Initial information received on 24-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 19-year-old pregnant female patient who was exposed to vaccine Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel] second dose in error with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported pregnant patient received a second dose of ADACEL in error with no reported adverse event occurred at unknown gestation period The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 22-Jan-2025, the pregnant patient received a 0.5 ml dose (dose 2) of suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine Suspension for injection of lot number: U8274AA and expiry date: 31-Aug-2026 via intramuscular route in the left deltoid in error also received dose 1 on 06-Dec-2024 with no reported adverse event (extra dose administered) (latency: on same day of 2nd dose). Reportedly, The patient is aware of the mistake and has not reported any reactions so far. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2823396 11 M IN 01/29/2025 MEN
 UNKNOWN MANUFACTURER
 U7540BD
Expired product administered, No adverse event Expired product administered, No adverse event
inappropriate use due to administration of expired MENQUADFI to patient with no reported adverse eve... inappropriate use due to administration of expired MENQUADFI to patient with no reported adverse event; Initial information received on 24-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case linked to US-SA-2025SA024785 (cluster) This case involves a 11 years old male patient who had inappropriate use due to administration of expired Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria vaccine toxoid, Pertussis vaccine acellular 5-component, Tetanus vaccine toxoid (Adacel); Influenza vaccine (Fluzone) and HPV vaccine VLP rL1 9v (yeast) (Gardasil 9) for Immunisation. On 23-Jan-2025, inappropriate use due to administration of expired dose (0.5 ml) of Meningococcal A-C-Y-W135 (T Conj) Vaccine, Solution for injection (lot U7540BD; expiry date: 31-Dec-2024) via unknown route in the left arm for Immunisation with no reported adverse event (expired product administered) (latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA024785:02386845 More
2823397 16 F IN 01/29/2025 MEN
 UNKNOWN MANUFACTURER
 U7540BD
Expired product administered, No adverse event Expired product administered, No adverse event
inappropriate use due to administration of expired MENQUADFI to patient with no reported adverse eve... inappropriate use due to administration of expired MENQUADFI to patient with no reported adverse event; Initial information received on 24-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 years old female patient to whom inappropriate use due to administration of expired Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] to patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Influenza vaccine (Fluzone). On 23-Jan-2025, the patient received a expired 0.5 ml dose of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine Solution for injection (strength: standard, frequency: once, expiry date: 31-Dec-2024 and lot U7540BD) via unknown route in the left arm as Immunization (expired product administered) (latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2823398 90 M MO 01/29/2025 FLU3
PNC20
 SANOFI PASTEUR
PFIZER\WYETH
 UT8470CA
No adverse event, Wrong product administered; No adverse event, Wrong product ad... No adverse event, Wrong product administered; No adverse event, Wrong product administered More
2nd dose FLUZONE HD was admisntered instead of Prevnar 20 with no reported adverse event; 2nd dose F... 2nd dose FLUZONE HD was admisntered instead of Prevnar 20 with no reported adverse event; 2nd dose FLUZONE HD was admisntered instead of Prevnar 20 with no reported adverse event; Initial information received on 24-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 90 years old male patient who received 2nd dose INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HD] was admisntered instead of PNEUMOCOCCAL VACCINE CONJ 20V (CRM197) (PREVNAR 20) with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 18-Oct-2024, the patient received 0.5 ml of 1 and dose 2 (on 22-Jan-2025) of suspect, INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE, Suspension for injection in pre-filled syringe (lot UT8470CA and expiry 30-JUN-2025) via intramuscular route in the left deltoid for Influenza instead of prevnar 20 with no reported adverse event (wrong product administered) (extra dose administered) (latency same day). Reportedly: Once they realized their mistake, they went ahead and gave the patient Prevnar 20. Medical assistant is asking if there would be safety concerns with regards to the situation. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2823399 F MN 01/29/2025 MEN
 UNKNOWN MANUFACTURER
Exposure during pregnancy, No adverse event Exposure during pregnancy, No adverse event
pregnant patient received Menquadfi with no reported adverse event; Initial information received on ... pregnant patient received Menquadfi with no reported adverse event; Initial information received on 24-Jan-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves an unknown age female patient who received meningococcal A-C-Y-W135 (T CONJ) vaccine [menquadfi] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported pregnant patient received Menquadfi with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unkown previous pregnancy/ies. On an unknown date, the patient received unknown dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection (Unknown strength, lot and expiry date) via unknown route in unknown administration site for Immunization with no adverse event (exposure during pregnancy) (Latency same day). There was no information related to Relevant prenatal testing after exposure. Reportedly, Nurse called on behalf of a physician. They said that the physician administered Menactra to a pregnant patient.informed the nurse that Menactra has been discontinued.The nurse clarified that they meant MENQUADFI instead of Menactra. Information on the batch number could not be requested corresponding to the one at time of event occurrence Additionally, at time of reporting, the outcome of the pregnancy is unknown. More
2823410 2.17 M HI 01/29/2025 FLU3
FLU3
FLU3
FLU3
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 UT8496MA
UT8496MA
UT8496MA
UT8496MA
Blood culture negative, CSF culture negative, CSF glucose normal, CSF protein no... Blood culture negative, CSF culture negative, CSF glucose normal, CSF protein normal, CSF red blood cell count; CSF test normal, CSF white blood cell count increased, Ear pain, Generalised tonic-clonic seizure, Immunoglobulin therapy; Magnetic resonance imaging head normal, Nucleic acid test, Otitis media, Polymerase chain reaction negative, Pyrexia; Respiratory pathogen panel, SARS-CoV-2 test negative More
Parent reported fever night after vac.Patient was seen in UCC 3 days after vaccination for complaint... Parent reported fever night after vac.Patient was seen in UCC 3 days after vaccination for complaint of fever and ear pain, dx with otitis media and prescribed antibiotics. On the way home, pt developed right sided tonic clonic seizure activity and taken to ED. Admitted and treated with antiseizure medication and antibiotics. Patient continued seizure and fever on anti-seizure meds and antibiotics. LP with 50 WBCs, <1 RBCs, protein 19, glucose 60. Transfered to Hospital for persistent seizure activity. symptoms improved after IVIG. No infectious etiology identified - some labs still pending. Autoimmune encephalitis panel pending. Planning discharge. Will need Neurology follow-up More
✓
2823412 U 01/29/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure
Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactiv... Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. The company considered the vaccination failure to be unrelated to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 18-JAN-2025 This case was reported by a consumer via interactive digital media. The patient had received Shingles vaccine and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, completion of primary vaccination schedule, time to onset of shingles and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix. More
2823413 75 F 01/29/2025 COVID19
 MODERNA
COVID-19, SARS-CoV-2 test, X-ray COVID-19, SARS-CoV-2 test, X-ray
Patient felt so sick, a little bit fever/it's still looks like she had a cold/weak/very sick/CO... Patient felt so sick, a little bit fever/it's still looks like she had a cold/weak/very sick/COVID.; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Patient felt so sick, a little bit fever/it's still looks like she had a cold/weak/very sick/COVID.) in a 75-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. The patient's past medical history included Lung disorder NOS (problems with lungs). On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On 30-Dec-2024, the patient experienced COVID-19 (Patient felt so sick, a little bit fever/it's still looks like she had a cold/weak/very sick/COVID.). At the time of the report, COVID-19 (Patient felt so sick, a little bit fever/it's still looks like she had a cold/weak/very sick/COVID.) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: COVID. On an unknown date, X-ray: X-ray was fine. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. Concomitant product use was not provided by the reporter. Patient never ever thought that she was gonna get the COVID because she was very careful. She was using the mask because she had a problem with lungs before. About 3 weeks ago, she felt so sick, a little bit fever, she think she got the COVID. When she got to the emergency room front door they came and they had that kind of the test for the COVID and inside of her nose and everything they did and they said go and sit in the waiting room. Now it was from the 30-Dec-2024, she went to the emergency room and they said, she got the COVID, but they took the X-ray from her lungs to be sure everything was fine with her lungs and they said, yes, the X-ray was fine, but she had the COVID and she had to go home and did not go with anybody around her because she was gonna spread the COVID to other people. She called her physician for lungs because she had a problem with her lungs before. Patient asked to quarantine for 4 weeks. From the 30-Dec-2024 she take the lots of the vitamin C and had lots of rest, and she was going to get better. She was a little bit better, but it still was going on with her. She was very, very weak, and she had a cold. When she was in a hospital in the emergency room, she heard that there was a medication that was gonna give it to the patient and stop the COVID. it was about 6-7 days ago. They said, usually we're gonna give that kind of the medication to the patient for the 3rd day of this COVID and it was too late for her and she could not be prescribe that kind of the medication for you. At the time of reporting patient was suffering so much and she was very, very sick. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not reported. Reporter did not allow further contact More
2823414 93 F AR 01/29/2025 RSV
RSV
RSV
 MODERNA
MODERNA
MODERNA
 3041770
3041770
3041770
Blood glucose normal, Breath sounds abnormal, Chest X-ray, Dysarthria, Dyspnoea;... Blood glucose normal, Breath sounds abnormal, Chest X-ray, Dysarthria, Dyspnoea; Feeling abnormal, Malaise, Paranasal sinus hypersecretion, Patient isolation, Productive cough; Respiratory syncytial virus test positive, Respiratory tract congestion, Rhonchi, Sputum discoloured, Sudden death More
Resident recieved vaccine 12/5/24. Came sick and tested positive for RSV on 12/27/24 Resident was on... Resident recieved vaccine 12/5/24. Came sick and tested positive for RSV on 12/27/24 Resident was on the mend feeling better, came off of isolation. Resident had sudden decline, sudden death. Was unable to got her to ER to be evaluated by ER before she declined. I was leaving the dining room from passing lunch meds I was passing by residents room when I heard resident yell help. Went into residents room resident had c/o SOB. Resident did not have O2 on. I reapplied O2. Resident also said that she had to go to thebathroom. CNA was walking by the room. I yelled out for CNA to take resident to the bathroom. I parked med cart in med room grabbed plus ox and glucometer. Another CNA grabbed v/s cart. Resident kept saying I don't feel good. I can't breath. BS was not low. SPO2 was not low. Resident was slurring her words. I did stroke assessment, it was WNL. I called supervisor RN and stated what was going on and that I was going to send to ER. CNAs and other nurse put resident on gurney as I printed off paperwork. I took resident down to ER. Resident passed in the elevator as we exited into ER. TOD was 1257. Notified Dr @ 1310. @1315 pronounced. @ 1415 Funeral home picked up. Resident coughing productively thick brown sputum. lung sounds rhonchi. o2 sat 85% room air. I have placed on o2@2lpm.nc. Chest x-ray results pending. Dr notified of resident condition and of chest x-ray results. new orders for levaquin 500 mg one daily x 5 days and decadron 8 mg IM daily x 1 dose. Family notified. Resident continues to have cough/congestion/sinus drainage. Lung sounds diminished. she is coughing productively yellow sputum. T 97.9 P 103 R 28 b/p 121/70 o2 sat 92% room air. I spoke with RN. new order received for chest x-ray today. Family notified. Resident coughing productively light yellow sputum, lung sounds diminished bases and rhonchi upper airway. T 97.9 P 96 R 32 b/p 103/59 o2 96% I have administered prn cough syrup and tylenol. results pcr fo follow. allergies: promethazine. Dr. notified new orders received for cefdinir 300 mg one bid x 5 days, decadron 8 mg IM x 1 injection, mupirocin ointment to bilateral nares bid x 5 days. Family notified. More
✓
2823465 42 M OK 01/29/2025 UNK
UNK
UNK
UNK
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 AW1669A
AW1669A
AW1669A
AW1669A
Computerised tomogram, Differential white blood cell count, Dissociation, Distur... Computerised tomogram, Differential white blood cell count, Dissociation, Disturbance in attention, Dizziness; Exertional headache, Fatigue, Full blood count, Head discomfort, Headache; Injection site pain, Magnetic resonance imaging head, Metabolic function test, Muscle spasms, Platelet count; Scan with contrast More
Moderate Injection site pain - no treatment, resolved Fatigue - ongoing Headache (day after only) - ... Moderate Injection site pain - no treatment, resolved Fatigue - ongoing Headache (day after only) - resolved Lightheadedness with exertion - short distance walking, standing for short periods - presented to neurologist but no treatment offered - has moderated but still encountering periods of lightheadedness Pressure in head that changed locations and intensity - no treatment - resolved Pain in head that changed locations and intensity - no treatment - resolved Disassociation, short term, possibly only one or two periods long enough to notice - no treatment - resolved Difficultly concentrating - no treatment - possibly ongoing Can't focus (long distance to short or vice versa) - no treatment - resolved Cramping in toes/feet hands/fingers calves- no treatment- frequency is reduced- ongoing, headaches after exertion - neurologist put on medications - frequency is reduced- ongoing , disassociation of feeling of orgasm with ejaculation - have been referred to urologist - ongoing More
2823466 90 M FL 01/29/2025 RSV
 PFIZER\WYETH
 Hy1813
No adverse event No adverse event
No adverse reaction reported when speaking to patient No adverse reaction reported when speaking to patient
2823467 30 F 01/29/2025 YF
YF
 SANOFI PASTEUR
SANOFI PASTEUR
 x3c283v
x3c283v
Arthralgia, Back pain, Diarrhoea, Injection site pain, Mobility decreased; Muscu... Arthralgia, Back pain, Diarrhoea, Injection site pain, Mobility decreased; Musculoskeletal stiffness, Myalgia, Pain, Pain in extremity More
Day 0 and Day 1 experienced injection site pain. Day 2 -Day 4 experienced extreme back pain and stif... Day 0 and Day 1 experienced injection site pain. Day 2 -Day 4 experienced extreme back pain and stiffness preventing me from turning my body at all, starting in the upper back and moving towards the lower back. Day 5 the back pain subsided but started to experience extreme hip pain and diarrhea. Day 6-Day 7 started having extreme leg pain where it hurt to stand but really hurt to sit. Radiating sharp pain down both legs; joints and muscles aching. Heating pads help. Today is Day 8 still having leg pain, knee pain, diarrhea, and some upper back pain is returning. More
2823468 85 M IA 01/29/2025 COVID19
 MODERNA
 3043924
Chest X-ray, Chest pain, Computerised tomogram thorax, Dyspnoea, Laboratory test Chest X-ray, Chest pain, Computerised tomogram thorax, Dyspnoea, Laboratory test
Patient reported having chest pains, SOB. Reported to ER and findings concluded a PE, no other reaso... Patient reported having chest pains, SOB. Reported to ER and findings concluded a PE, no other reasoning for this to develop. More
✓
2823469 10 M WI 01/29/2025 COVID19
FLU3
HEPA
HPV9
TDAP
VARCEL
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 B0004
j245k
a3x2k
y007197
3re73
y011017
No adverse event, Product administered to patient of inappropriate age; No adver... No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age More
Client was given SPIKEVAX12+, but he was 10 years old at the time of administration. Client did not ... Client was given SPIKEVAX12+, but he was 10 years old at the time of administration. Client did not experience any symptoms or adverse effects after receiving the vaccine. More
2823470 0.25 F MA 01/29/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 4T93R
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Adult hepatitis A dose was administered instead of pediatric hepatitis A. Parent contacted and info... Adult hepatitis A dose was administered instead of pediatric hepatitis A. Parent contacted and informed of adverse event, confirmed with parent that child is okay. Consulted with rendering provider regarding vaccine error. More
2823471 75 M 01/29/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
Extra dose administered Extra dose administered
patient received RSV vaccine twice. Initial dose 7/24/24 patient received RSV vaccine twice. Initial dose 7/24/24
2823472 64 F TN 01/29/2025 COVID19
 PFIZER\BIONTECH
 Not recorded
Breakthrough COVID-19 Breakthrough COVID-19
Covid-19 Breakthrough infection Covid-19 Breakthrough infection
✓
2823473 3 F VA 01/29/2025 MMRV
 MERCK & CO. INC.
 y017205
Underdose Underdose
As the needle was being withdrawn from the patient's arm, a couple drops of the vaccine spilled... As the needle was being withdrawn from the patient's arm, a couple drops of the vaccine spilled down the patient's arm. More
2823474 0.33 M WI 01/29/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 AMVA983A
No adverse event, Wrong product administered No adverse event, Wrong product administered
Wrong vaccine administered; no adverse reactions noted Wrong vaccine administered; no adverse reactions noted
2823475 45 F 01/29/2025 TD
 MASS. PUB HLTH BIOL LAB
 A146A
Extra dose administered Extra dose administered
patient already received Td on 2/22/22 patient already received Td on 2/22/22
2823476 80 F IA 01/29/2025 PNC21
 MERCK & CO. INC.
 y013009
Chills, Dizziness, Injection site erythema, Injection site swelling, Pyrexia Chills, Dizziness, Injection site erythema, Injection site swelling, Pyrexia
Redness/swelling of injection arm, light headedness, fever/chills Redness/swelling of injection arm, light headedness, fever/chills
2823477 80 F TN 01/29/2025 COVID19
 MODERNA
 010A21A
Breakthrough COVID-19 Breakthrough COVID-19
Covid-19 Breakthrough Infection Covid-19 Breakthrough Infection
✓
2823478 40 F WY 01/29/2025 FLU3
FLU3
 SANOFI PASTEUR
SANOFI PASTEUR
 TFAA2432
TFAA2432
Arteriogram carotid, Computerised tomogram head, Metabolic function test, Nerve ... Arteriogram carotid, Computerised tomogram head, Metabolic function test, Nerve block, New daily persistent headache; Scan with contrast, Spinal X-ray More
New Daily Persistent Headache. Started 10/20/2024 and continues every single day through today. Cons... New Daily Persistent Headache. Started 10/20/2024 and continues every single day through today. Constant headache, only relieved by laying down. More
2823479 58 F LA 01/29/2025 PNC21
 MERCK & CO. INC.
 Y013009
Injection site erythema, Injection site swelling Injection site erythema, Injection site swelling
red slightly swollen at injection site red slightly swollen at injection site
2823480 64 F FL 01/29/2025 FLU3
 SEQIRUS, INC.
 946627
Magnetic resonance imaging, Unevaluable event Magnetic resonance imaging, Unevaluable event
n/a n/a
2823481 42 F MN 01/29/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 G2457
Asthenia, Hypoaesthesia, Injection site pain Asthenia, Hypoaesthesia, Injection site pain
Pain in Rt upper arm to elbow unresolved after 2 months. Numbness and weakness. Pain in Rt upper arm to elbow unresolved after 2 months. Numbness and weakness.
2823482 22 F UT 01/29/2025 COVID19
 PFIZER\BIONTECH
 Pfizer
Blood test normal, Electroencephalogram normal, Generalised tonic-clonic seizure... Blood test normal, Electroencephalogram normal, Generalised tonic-clonic seizure, Partial seizures, Road traffic accident More
Grand Mal seizure within 24 hours after injection. Reoccurring and ongoing grand Mal and focal seizu... Grand Mal seizure within 24 hours after injection. Reoccurring and ongoing grand Mal and focal seizures since vaccination. I deal with this daily. No family records of seizure on either of my parents side. I have been hospitalized many times. I have suffered a car accident, and paid many, many medical bills including doctor visits, overnight hospitalization, ambulance bills, and medicine to treat my symptoms. More
✓ ✓ ✓
2823483 62 M MI 01/29/2025 FLU3
 SEQIRUS, INC.
 388499
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Patient was 62 at time of vaccination but given the dose approved for patients who are 65+, patient ... Patient was 62 at time of vaccination but given the dose approved for patients who are 65+, patient had no adverse reactions at the time of vaccination. More
2823484 4 F NM 01/29/2025 DTAPIPVHIB
MMRV
 SANOFI PASTEUR
MERCK & CO. INC.
 UK109AA
Y015357
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Pentacel (DTaP-IPV/Hib) administered instead of Kinrix (DTaP-IPV). The patient received 5 doses of H... Pentacel (DTaP-IPV/Hib) administered instead of Kinrix (DTaP-IPV). The patient received 5 doses of Hib after this Pentacel vaccination. More
2823485 12 F MN 01/29/2025 HPV9
 MERCK & CO. INC.
Herpes zoster, Rash Herpes zoster, Rash
Patient was diagnosed with shingles on 01/29/2025 in the same arm the Gardisil 9 injection was given... Patient was diagnosed with shingles on 01/29/2025 in the same arm the Gardisil 9 injection was given. The shingles rash began on 01/26/2025. It is highly unusual for children to contract Shingles. More
2823486 80 M MI 01/29/2025 COVID19
FLU3
 MODERNA
SEQIRUS, INC.
 3043836
388499
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
Patient received the 2024/2025 formulation of Fluad and Spikevax on 9/25/24 at a visit with his doct... Patient received the 2024/2025 formulation of Fluad and Spikevax on 9/25/24 at a visit with his doctor's office and again on 12/2/24 at an immunization clinic put on by Pharmacy. No adverse reactions at the time of vaccination. More
2823487 57 F 01/29/2025 MMR
 MERCK & CO. INC.
Extra dose administered Extra dose administered
Patient received a second M-M-R II vaccines 3 days after previously receiving another M-M-R II vacc... Patient received a second M-M-R II vaccines 3 days after previously receiving another M-M-R II vaccine at another pharmacy. Patient came in another day with their information from another pharmacy showing they got the M-M-R II already but did not mention at the time of vaccine that they received any vaccines recently. More
2823488 42 F NC 01/29/2025 HEP
 GLAXOSMITHKLINE BIOLOGICALS
 553J7
Underdose Underdose
Gave pediatric dose to adult patient. Gave pediatric dose to adult patient.
2823489 67 M 01/29/2025 MMR
 MERCK & CO. INC.
Extra dose administered Extra dose administered
Patient received a second M-M-R II vaccines 3 days after previously receiving another M-M-R II vacci... Patient received a second M-M-R II vaccines 3 days after previously receiving another M-M-R II vaccine at another pharmacy. Patient came in another day with their information from another pharmacy showing they got the M-M-R II already but did not mention at the time of vaccine that they received any vaccines recently. Two patients came in together, report for other patient already submitted. More
2823490 75 M FL 01/29/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255T2
Extra dose administered Extra dose administered
Duplicate RSV vaccine was given to patient. Patient had a dose of the vaccine on 09/15/23 and again ... Duplicate RSV vaccine was given to patient. Patient had a dose of the vaccine on 09/15/23 and again on 01/27/25. More
2823491 60 F IA 01/29/2025 COVID19
COVID19
 JANSSEN
JANSSEN
 042A21A
042A21A
Anti-GAD antibody positive, Blood glucose increased, Glycosylated haemoglobin in... Anti-GAD antibody positive, Blood glucose increased, Glycosylated haemoglobin increased, Haemoptysis, Latent autoimmune diabetes in adults; Mycobacterium avium complex infection More
Latent Autoimmune Diabetes in Adults (LADA) diagnosed. Initial diabetes diagnosis Blood sugar of 488... Latent Autoimmune Diabetes in Adults (LADA) diagnosed. Initial diabetes diagnosis Blood sugar of 488mg/dl and HbA1c of 8.4 discovered in ER visit for Hemoptysis secondary to a later discovered mycobacterium intracellulare infection in left lobe of lung. This infection occurred likely from a decreased immune system caused by elevated blood glucose. Follow-up with endocrinologist found positive Antibodies to glutamic acid decarboxylase (GAD). Prior to Covid-19 vaccine fasting blood glucose results were below 100mg/dl. More
✓ ✓
2823492 89 F TN 01/29/2025 COVID19
 MODERNA
 EW0167
Breakthrough COVID-19 Breakthrough COVID-19
Covid-19 Breakthrough Infection Covid-19 Breakthrough Infection
✓
2823493 54 F NC 01/29/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 U8015AA
Abdominal discomfort, Chills, Diarrhoea, Vomiting Abdominal discomfort, Chills, Diarrhoea, Vomiting
Upset stomach at 3 pm/vomiting and diarrhea started at 4 pm. until 7 pm/cold chills from 6 pm to 11p... Upset stomach at 3 pm/vomiting and diarrhea started at 4 pm. until 7 pm/cold chills from 6 pm to 11pm/ sensitive stomach until Jan. 14th. More
2823494 43 F TX 01/29/2025 COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
 3043823
3043823
3043823
Arthralgia, Chest pain, Deep vein thrombosis, Fibrin D dimer increased, Internat... Arthralgia, Chest pain, Deep vein thrombosis, Fibrin D dimer increased, International normalised ratio normal; Muscular weakness, Prothrombin time normal, Skin discolouration, Subclavian vein thrombosis, Superficial vein prominence; Ultrasound Doppler abnormal More
Subclavian DVT in right arm. Observed prominent veins on right shoulder and chest evening January 12... Subclavian DVT in right arm. Observed prominent veins on right shoulder and chest evening January 12th. Some weakness and discoloration in right arm. Saw PCP on January 13th, d-dimer performed in office. Ultrasound performed evening january 13th, DVT diagnosed. Referred to ER. Prescribed Eliquis Starter Pack for DVT/PE, began taking evening January 13th. Currently on Day 17 of treatment, minor improvement in symptoms but veins still prominently visible, weakness and discolouration in right arm persists, and some pain in right shoulder/chest area. No personal history of DVT, no family history of DVT except assosciated with Stage 4 lung cancer (mother, age 77). More
✓
📋 Privacy Policy & Data Disclaimer